Abstract

Nourbakhsh et al. found that amantadine, modafinil, and methylphenidate were no better than placebo at reducing fatigue after six weeks. Consequently, physicians have raised ethical concerns about prescribing these medicines as “placebos.” Such concerns are premature and overshadowed by ethical concerns surrounding the habit-forming potential of modafinil and methylphenidate.